Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5%

Keryx Biopharmaceuticals Inc. (KERX) saw a big move last session, as the company’s shares fell by nearly 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $15.63–$18.19 in the past one-month time frame, showed a sharp decline Friday at $17.01.

This slump shouldn’t be too much of a surprise to investors, as this biopharmaceutical company has seen 5 negative revisions in the past few weeks and its current year loss consensus has widened over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

KERX currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the Med-Biomed/Generic industry include Cambrex Corporation. (CBM), China Biologic Products, Inc. (CBPO) and Gilead Sciences Inc. (GILD). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>





KERYX BIOPHARMACEUTICALS INC (KERX): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

CHINA BIOLOGIC PRODUCTS INC (CBPO): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report


Zacks Investment Research